Fusion gene test for diagnosing and monitoring chronic myeloid and lymphoid leukemias.
The BCR-ABL1 gene fusion is commonly seen in chronic myeloid leukaemia and acute lymphoblastic leukaemia. The detection and quantitation of transcript levels is important in the diagnosis, treatment, and monitoring of the patients with these disorders.
BCR-ABL
Used in the differential diagnosis, monitoring, and for treatment selection in patients with laboratory evidence of certain types of leukaemia.
BCR/ABL1 fusion
Real-time PCR
2 – 4 days
73314 – criteria apply
If not MBS eligible please contact 1800 822 999 for details
Standard pathology request form
Blood 6mL EDTA tube or Bone Marrow 4mL EDTA tube
Blood or bone marrow
Bone marrow and diagnostic specimens must be received by the laboratory within 48 hours of collection. No collections Friday. Specimens for monitoring purposes must be received in the laboratory within 72hrs from collection. Collection can occur any day.
